TearSolutions advances Lacripep into phase 2 following dual FDA designations in neurotrophic keratitisByOptometry Times Staff ReportsJune 3rd 2026
Recent study findings may prove previous estimations of retinal cell communication, low-light visionByYao Xue, PhD,Z. Jimmy Zhou, PhD,Seunghoon Lee, PhD,Marcello DiStasio, MD, PhD,Jordana Joy, EditorJune 3rd 2026
Hybrid AI model distinguishes keratoconus from healthy eyes with 90% accuracyBySheryl StevensonJune 3rd 2026